Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | RORC | P51449 | 4/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | TP53 | P04637 | 3/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | PPARG | P37231 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | THPO | P40225 | 1/20 | 0.63 |
| ▸ | MTOR | P42345 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6202524 | 0.98 | KMT2A (0.61) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL8450902 | 0.98 | KMT2A (0.61) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL6392429 | 0.98 | KMT2A (0.61) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL27637460 | 0.91 | KMT2A (0.55) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL10953243 | 0.87 | HSD17B10 (0.62) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL9074113 | 0.85 | RORC (0.53) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL398463 | 0.85 | HSD17B10 (0.60) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL231457 | 0.85 | KMT2A (0.72) | KMT2ACYP3A4MAPTMAPK1SMN1; SMN2 | |
| SCHEMBL1789120 | 0.84 | KMT2A (0.75) | KMT2ARORCCYP3A4MAPTMEN1 | |
| SCHEMBL8447120 | 0.84 | KMT2A (0.70) | KMT2ACYP3A4MAPTMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119930435-A | Preparation method of mesalamine intermediate | 珠海润都制药股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119569654-A | 9-Aminoacridine compound with multi-electron-withdrawing substituent, and preparation method and application thereof | 郑州大学 | 2025-03-07 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-116199571-A | Method for controlling content of organic carboxylic acid in synthesis process of benzophenone photoinitiator | 宜都市友源实业有限公司 | 2023-06-02 | — | — | CN | claimed |
| CN-112125926-B | Novel chlorine-containing carboxylic acid metal complex, preparation method and application thereof | 广西民族师范学院 | 2023-04-25 | — | — | CN | claimed |
| CN-110133118-B | Method for determining related substances of mesalazine enteric sustained-release tablets | 重庆健能医药开发有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-109799292-B | Mesalazine enema related substance determination method | 重庆健能医药开发有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-214131604-U | Double-kettle type continuous nitration reaction device for producing 2-chloro-5-nitrobenzoic acid | 武汉伯业科技发展有限公司 | 2021-09-07 | — | — | CN | claimed |
| CN-213791646-U | Temperature-adjustable reaction device for producing 2-chloro-5-nitrobenzoic acid | 武汉伯业科技发展有限公司 | 2021-07-27 | — | — | CN | claimed |
| EP-0780376-A1 | 2-Acylamino-9-aryl-acridines, process for their preparation and light-sensitive compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-06-25 | — | — | EP | claimed |
| EP-0751768-A1 | ANTI-VIRAL AND ANTI-CANCER AGENTS | RADOPATH LIMITED (GB) | 1997-01-08 | — | — | EP | claimed |
| WO-1996029067-A1 | ANTI-VIRAL AND ANTI-CANCER AGENTS | RADOPATH LIMITED (GB) | 1996-09-26 | — | — | WO | claimed |
| EP-0700287-A1 | ARYLATING MEDICAMENTS | RADOPATH LIMITED (GB) | 1996-03-13 | — | — | EP | claimed |
| EP-0677292-A1 | Anti-viral and anti-cancer agents | RADOPATH LIMITED (GB) | 1995-10-18 | — | — | EP | claimed |
| WO-1995024897-A1 | ANTI-VIRAL AND ANTI-CANCER AGENTS | RADOPATH LIMITED (GB) | 1995-09-21 | — | — | WO | claimed |
| WO-1994027584-A2 | ARYLATING MEDICAMENTS | RADOPATH LIMITED (GB) | 1994-12-08 | — | — | WO | claimed |
| US-5277790-A | Non-cyanide electroplating solution for gold or alloys thereof | TECHNIC INCORPORATED (US) | 1994-01-11 | — | — | US | claimed |
| US-4179476-A | Semi-continuous process for obtaining amino compounds | CIBA-GEIGY CORPORATION (US) | 1979-12-18 | — | — | US | claimed |
| US-3936509-A | Process for separating dimethyl naphthalenes comprising 2,6-dimethyl naphthalenes as main component | TEIJIN LIMITED (JA) | 1976-02-03 | — | — | US | claimed |